There are already an estimated 50 million people in the EU suffering from two or more long-term conditions and by 2020, when a quarter of Europeans will be over 60 years of age, multi-morbidity is likely to be the norm rather than the exception. Multi-morbidity has significant implications for the economy, labour market, social security […]
The last 50 years have witnessed remarkable improvements in CVD outcomes. Since 1960, overall CVD mortality rates have fallen by over 60{ddf8d179d1bf712bb2a88ff2ad95ebdf63eaa5463c845d2f093b25848387ba96}, but these improvements are not evenly spread across OECD countries, and the rising prevalence of diabetes and obesity are threatening to offset gains. This report examines how countries perform in their ability to
Cardiovascular Disease and Diabetes: Policies for Better Health and Quality of Care Read More »
Over 13 million people in the WHO European Region are living with chronic hepatitis B infection and over 15 million with chronic hepatitis C infection. Between them, these two diseases lead to 400 deaths in the Region every day. Many cases of viral hepatitis remain asymptomatic until decades after infection, slowly destroying the liver and
Viral hepatitis—400 deaths a day in Europe Read More »
Many countries are looking at innovative ways to redesign delivery systems to provide appropriate support to people with long-standing health problems. This book looks at the experience of 12 European countries and evaluates the outcomes of their different initiatives. To read the reports, click here on http://who.us4.list-manage.com
Assessing chronic disease management in European health systems. Read More »
While much has been done in terms of health promotion and primary prevention of chronic diseases across Europe, there are still gaps and needs that require urgent attention, according to a new report from the Joint Action on Addressing Chronic Diseases and Healthy Ageing across the Life Cycle (JA-CHRODIS). The report provides a comparative overview of
Reducing the burden of chronic diseases Read More »
The EMPATiE project has analysed patient empowerment (PE) for patients with chronic diseases. It has produced a catalogue of best practices in PE, an analysis of barriers to PE, suggestions on how best to transfer good practices between countries and suggestions for EU collaboration on PE over the next decade. To download the final report,
Patient Empowerment Read More »
This report summarizes the best available evidence for a link between psychosocial factors and morbidity and mortality from cardiovascular diseases and cancer in Europe. The psychosocial factors repeatedly identified as related to chronic diseases include high job demand, low autonomy, low control or high effort-reward imbalance, interpersonal conflicts and low social support or low trust. Psychosocial factors
Psychosocial factors linked to chronic diseases Read More »
A disease or disorder is defined as rare in the EU when it affects less than five in every 10,000 citizens. However, because there are so many different rare diseases – between 6,000 and 8,000 – between 30 and 40 million people in the EU, many of whom are children, suffer from rare diseases. Most rare
The rising burden of chronic illness, in particular the increase in the number of people with multiple health problems, is a challenge to health systems globally. Associated premature mortality and reduced physical functioning, along with higher use of health services and related costs, are among the key concerns faced by policy-makers and practitioners. Delivery systems
Assessing chronic disease management in European health systems Read More »
According to a new WHO report, 16 million people die before the age of 70 from heart and lung diseases, stroke, cancer and diabetes. The report, “Global status report on non-communicable diseases 2014” urges governments to act to meet global targets and reduce the NCD epidemic. An investment of just US$ 1-3 per person per
Non-communicable diseases (NCDs) prematurely take 16 million lives a year Read More »
